C

Catalyst Pharmaceuticals

D
CPRX
USD
0.5
(2.1988%)
Market Closed
59,013.00
Volume
1.565
EPS
-
Div Yield
41.500
P/E
2,758,306,726.28
Market Cap
Today
2.1988%
1 Week
6.557%
1 Month
17.790%
6 Months
53.450%
12 Months
80.926%
Year To Date
38.416%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ADMP
(%)
USD
A
ANIP
1
(1.7449%)
USD
A
ARWR
0.055
(0.2579%)
USD
E
ERYP
-0.0267
(-3.4465%)
USD
I
INO
-0.13
(-2.2968%)
USD
K
KPTI
0.0008
(0.0909%)
USD
M
MRTX
(%)
USD
R
RARE
-1.75
(-3.3531%)
USD

Title:
Catalyst Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
Do you need help or have a question?
Contact Us